A
14.85
0.39 (2.70%)
Penutupan Terdahulu | 14.46 |
Buka | 14.59 |
Jumlah Dagangan | 64,336 |
Purata Dagangan (3B) | 72,759 |
Modal Pasaran | 212,969,792 |
Harga / Pendapatan (P/E Ke hadapan) | 50.00 |
Harga / Jualan (P/S) | 1.90 |
Harga / Buku (P/B) | 1.43 |
Julat 52 Minggu | |
Tarikh Pendapatan | 9 May 2025 |
Margin Keuntungan | -47.02% |
Margin Operasi (TTM) | -0.33% |
EPS Cair (TTM) | -0.600 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -28.80% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 16.84% |
Nisbah Semasa (MRQ) | 4.88 |
Aliran Tunai Operasi (OCF TTM) | 5.40 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 37.84 M |
Pulangan Atas Aset (ROA TTM) | -1.19% |
Pulangan Atas Ekuiti (ROE TTM) | -4.82% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
Stok | Anika Therapeutics Inc. | Menurun | Menurun |
AISkor Stockmoo
1.1
Konsensus Penganalisis | -0.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | 2.0 |
Purata | 1.13 |
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - Specialty & Generic |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 3.97% |
% Dimiliki oleh Institusi | 89.79% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Capital Management Corp /Va | 31 Dec 2024 | 325,545 |
Julat 52 Minggu | ||
Median | 19.00 (27.95%) | |
Jumlah | 1 Beli |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Barrington Research | 12 May 2025 | 19.00 (27.95%) | Beli | 0.000 |
13 Mar 2025 | 20.00 (34.68%) | Beli | 15.21 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
09 May 2025 | Pengumuman | Anika Reports First Quarter 2025 Financial Results |
25 Apr 2025 | Pengumuman | Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 |
07 Apr 2025 | Pengumuman | Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
12 Mar 2025 | Pengumuman | Anika Reports Fourth Quarter and Full Year 2024 Financial Results |
07 Mar 2025 | Pengumuman | Anika Completes Divestiture of Parcus Medical |
26 Feb 2025 | Pengumuman | Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 |
25 Feb 2025 | Pengumuman | Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |